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Introduction
Hemichorea-Hemiballism (HCHB) is a well-known complication of  
hyperglycemia which can also be seen with new-onset diabetes.1 The 
prognosis of  this condition is variable with improvement, disappear-
ance, and persistence of  chorea reported in the literature.1 The patho-
physiology of  this disorder is poorly understood and T1 hyperintensity 
on brain MRI contralateral to the side of  chorea is a well-known imag-
ing finding.2 The purpose of  this case is to discuss the abnormality on 
DaT scan in a case of  HCHB and utilization of  DaT scan in the correct 
clinical context.
Case report
A 57-year-old woman with a past medical history of  poorly controlled 
diabetes mellitus type 2 developed numbness and spontaneous abnor-
mal movements of  the left upper extremity 1 week after a fall on her left 
shoulder. Her blood glucose at that time was noted to be over 500 mg/
dL. Her physical examination showed left hemichorea and the absence 
of  hypokinesia (video 1). Magnetic resonance imaging (MRI) head with-
out contrast demonstrated increased T1 signal intensity in the lenticular 
nucleus on both sides (Figure 1). Her final diagnosis was hyperglyce-
mic-hemichorea, and amantadine was prescribed.
The phenomenology of  the movement was considered to be tremor at 
an outside center so a DaT scan was requested. DaT scan single-photon 
emission computerized tomography (SPECT) was completed with [123I]
FP-CIT, which demonstrated absent uptake in the bilateral putamen and 
moderately diminished uptake in the right caudate head as noted in 
Figure 2. She was diagnosed with parkinsonism and referred to the move-
ment disorders center for further evaluation.
Discussion
We present a case that demonstrates the importance of  utilizing the 
DaT scan imaging technique in the correct context. The phenomenol-
ogy of  this patient’s movement disorder was consistent with chorea 
because it was not rhythmic in contrast to tremor and was flowing in 
nature.3 It must be emphasized that the diagnosis of  parkinsonism 
relies on clinical features such as bradykinesia, rigidity, etc., and 
approach to a patient with an abnormal movement disorder relies 
on good clinical examination.4 DaT scan utilizes radiotracers such as 
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Abstract
Background: Hyperglycemic-hemichorea is a well-established clinical entity which leads to signal changes on brain MRI. We are reporting a case of  hyperglyce-
mic-hemichorea where the DaT scan showed reduced uptake bilaterally.
Case Report: A 57-year-old female was seen in the clinic for hemichorea due to hyperglycemia. Her brain magnetic resonance imaging (MRI) showed increased 
T1 signal intensity in bilateral lenticular nuclei and the DaT scan showed reduced uptake on both sides.
Discussion: This case highlights the importance of  performing a DaT scan in the correct clinical context, as an abnormality on brain MRI can lead to false- 
positive DaT scan results.
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β-CIT [123I-CIT (2β-carbomethoxy-3β-(4-iodophenyl) tropane)], 
123I-ioflupane [123I-N-ω-fluoropropyl-β CIT] (abbreviated 123I-FP-
CIT), or 99mTc-TRODAT [2-[[2-[[[3-(4-chlorophenyl)-8- methyl-8-
azabicyclo[3.2.1]oct-2-yl]methyl] (2-mercaptoethyl )amino]
ethy]-amino]ethanethiolato-(3-)-N2,N2’,S2,S2’]oxo-[1R-(exo-exo)] 
that bind dopamine transporter (DAT) on the pre-synaptic dopami-
nergic nerve terminals.5,6 123I-FP-CIT is the most commonly used 
radiotracer due to the shorter interval between administration and 
imaging, and lack of  competitive inhibition from dopamine allowing 
the patient to continue taking levodopa therapy.6 DaT concentration is 
a marker for dopamine terminal integrity, hence decreased radiotracer 
uptake is consistent with degeneration of  dopaminergic projections 
from the substantia nigra and correlates with high specificity for 
 parkinsonism.7 DaT scan is only approved to differentiate essential 
tremor (ET) from other neurodegenerative disorders (https://www.
Figure 2. DaT Scan. DaT SPECT with [123I] FP-CIT Shows Absent Uptake 
in the Bilateral Putamen and Moderately Diminished Uptake in the Right 
Caudate Head.
Video 1. Chorea in the Left Upper and Left Lower Extremity. There is 
no evidence of  parkinsonism on examination.
Figure 1. MRI Brain. Axial T1 Image Shows Hyperintensity in the Bilateral 
Basal Ganglia.
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accessdata.fda.gov/drugsatfda_docs/label/2011/022454Orig-
1s000Lbl.pdf  [accessed: October 6, 2019]). The pattern of  dopami-
nergic cell loss seen in parkinsonian syndromes follows a rostral-caudal 
gradient typically starting with the putamen first and later involving 
the caudate.6 However, when MRI signal abnormalities are present in 
the basal ganglia, DaT scan results must be interpreted with caution.8 
Some reported cases in the literature9–13 attribute parkinsonism due to 
abnormal DaT scan despite abnormality on structural imaging. It is 
therefore imperative that the results of  DaT scan are interpreted in 
the context of  structural imaging findings. An abnormality on struc-
tural imaging always gives false-positive results on Positron Emission 
Tomography (PET) or SPECT imaging as seen with stroke, gliosis, 
etc.14 The lesions involving the basal ganglia can lead to either a hypo-
kinetic or hyperkinetic movement disorder depending on the involved 
pathway. Hence, a patient with a structural abnormality in the basal 
ganglia can have a hyperkinetic movement disorder despite an abnor-
mal DaT scan. F-18 labeled deoxyglucose (FDG)-PET scan in patients 
with hyperglycemic-hemichorea has shown reduced metabolism in the 
basal ganglia contralateral to the side of  chorea.15 There is a possible 
failure of  metabolism in the affected basal ganglia or transient isch-
emia leading to swollen astrocytes (due to injury) and abnormality on 
brain MRI.15 The most likely explanation for an abnormal DaT scan 
in our case is the structural change seen on brain MRI (swollen astro-
cytes).16,17 Another case of  hyperglycemic HCHB with an abnormal 
DaT scan on the side of  abnormal brain MRI has been reported but 
this represents a false-positive finding in the wake of  structural abnor-
mality on brain MRI.18
In our case, DaT scan results indicative of  a parkinsonian uptake pat-
tern only contributed to diagnostic confusion since the patient did not 
have exam findings suggestive of  parkinsonism and had T1 signal abnor-
mality on MRI brain corresponding to decreased radiotracer uptake.
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